Charles Schwab’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $107M | Buy |
|
|||||
|
2025
Q2 | $108M | Sell |
|
|||||
|
2025
Q1 | $97.2M | Sell |
|
|||||
|
2024
Q4 | $79.9M | Buy |
|
|||||
|
2024
Q3 | $84.9M | Buy |
|
|||||
|
2024
Q2 | $50.1M | Buy |
|
|||||
|
2024
Q1 | $55.7M | Buy |
|
|||||
|
2023
Q4 | $49.7M | Buy |
|
|||||
|
2023
Q3 | $44.8M | Buy |
|
|||||
|
2023
Q2 | $45.4M | Buy |
|
|||||
|
2023
Q1 | $50.7M | Buy |
|
|||||
|
2022
Q4 | $53.8M | Buy |
|
|||||
|
2022
Q3 | $51.3M | Buy |
|
|||||
|
2022
Q2 | $49.1M | Buy |
|
|||||
|
2022
Q1 | $41.9M | Buy |
|
|||||
|
2021
Q4 | $39.4M | Buy |
|
|||||
|
2021
Q3 | $34.2M | Buy |
|
|||||
|
2021
Q2 | $10.9M | Buy |
|
|||||
|
2021
Q1 | $10.7M | Buy |
|
|||||
|
2020
Q4 | $9.04M | Sell |
|
|||||
|
2020
Q3 | $9.04M | Buy |
|
|||||
|
2020
Q2 | $7.85M | Buy |
|